SentreHEART announces first clinical use of the Eclipse surgical left atrial appendage closure device

344

 

eclipseSentreHEART has announced it has treated the first patients using the Eclipse surgical device for left atrial appendage (LAA) closure. Krzysztof Bartus (Jagiellonian University, Department of Cardiovascular and Transplant Surgery in Krakow, Poland) performed the procedures.

“The procedures went exceedingly well. Complete closure was achieved in all cases. The ultra-low profile of the Eclipse improves visualisation during placement, is easy to use and unlike other surgical solutions, does not require excessive grasping or manipulation of the left atrial appendage to close around its base,” said Bartus.

“The Eclipse surgical device, along with the Lariat Suture Delivery System, for LAA closure uniquely positions SentreHEART as the only company providing an option for both percutaneous and surgical closure of the left atrial appendage in Europe,” said Russ Seiber, president and CEO of SentreHEART. “Eclipse offers surgeons an intuitive and easy to use solution for immediate and complete LAA closure. We were pleased to have D. Bartus and his team involved in the first clinical use of the Eclipse.”

The Eclipse surgical left atrial appendage closure device is CE marked for left atrial appendage closure under direct visualisation. Eclipse enables remote delivery of a 50mm pre-tied suture loop in a controlled and precise manner with immediate and complete LAA closure.